Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia

Severe aplastic anemia (SAA) is a hematological condition with high morbidity and mortality. Treatment with immunosuppressive agents is alternative treatment if bone marrow transplant is not available. Several studies reported predictors of successful treatment in patients with SAA. However, the res...

Full description

Bibliographic Details
Main Authors: Thanakrit Somprasertkul, Weerayaporn Trirattanapikul, Sittichai Khamsai, Verajit Chotmongkol, Kittisak Sawanyawisuth
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Medicine in Drug Discovery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S259009862400006X
_version_ 1797272453089591296
author Thanakrit Somprasertkul
Weerayaporn Trirattanapikul
Sittichai Khamsai
Verajit Chotmongkol
Kittisak Sawanyawisuth
author_facet Thanakrit Somprasertkul
Weerayaporn Trirattanapikul
Sittichai Khamsai
Verajit Chotmongkol
Kittisak Sawanyawisuth
author_sort Thanakrit Somprasertkul
collection DOAJ
description Severe aplastic anemia (SAA) is a hematological condition with high morbidity and mortality. Treatment with immunosuppressive agents is alternative treatment if bone marrow transplant is not available. Several studies reported predictors of successful treatment in patients with SAA. However, the results are not consistent and not specific to anti-thymocyte globulin and cyclosporine. This study aimed to evaluate the predictor of response to treatment in this specific regimen. This study was a retrospective cohort study. The inclusion criteria were adult patients with SAA or very SAA who received this regimen. Clinical factors predictive of response to treatment were computed. There were 92 patients met the study criteria. Of those, 56 patients (60.87%) were in a group of response to treatment. There were nine factors in the predictive model for good response to treatment. Only body mass index was independently associated with response to treatment with an adjusted odds ratio of 1.31 (95% confidence interval of 1.04, 1.67). Age or hematological laboratory factors such as lymphocyte or neutrophil count were not significant. Low body mass index may be less likely to response to immunosuppressive treatment in patients with severe or very severe aplastic anemia.
first_indexed 2024-03-07T14:28:25Z
format Article
id doaj.art-ec70c000edc248e5b8b1ae71404e266c
institution Directory Open Access Journal
issn 2590-0986
language English
last_indexed 2024-03-07T14:28:25Z
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Medicine in Drug Discovery
spelling doaj.art-ec70c000edc248e5b8b1ae71404e266c2024-03-06T05:28:36ZengElsevierMedicine in Drug Discovery2590-09862024-06-0122100181Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemiaThanakrit Somprasertkul0Weerayaporn Trirattanapikul1Sittichai Khamsai2Verajit Chotmongkol3Kittisak Sawanyawisuth4Department of Medicine, Khon Kaen Hospital, Khon Kaen, ThailandDepartment of Medicine, Khon Kaen Hospital, Khon Kaen, ThailandDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, ThailandDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, ThailandDepartment of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Corresponding author at: Department of Medicine, Faculty of Medicine, Khon Kaen University, 123 Mitraparp road, Khon Kaen 40002, Thailand.Severe aplastic anemia (SAA) is a hematological condition with high morbidity and mortality. Treatment with immunosuppressive agents is alternative treatment if bone marrow transplant is not available. Several studies reported predictors of successful treatment in patients with SAA. However, the results are not consistent and not specific to anti-thymocyte globulin and cyclosporine. This study aimed to evaluate the predictor of response to treatment in this specific regimen. This study was a retrospective cohort study. The inclusion criteria were adult patients with SAA or very SAA who received this regimen. Clinical factors predictive of response to treatment were computed. There were 92 patients met the study criteria. Of those, 56 patients (60.87%) were in a group of response to treatment. There were nine factors in the predictive model for good response to treatment. Only body mass index was independently associated with response to treatment with an adjusted odds ratio of 1.31 (95% confidence interval of 1.04, 1.67). Age or hematological laboratory factors such as lymphocyte or neutrophil count were not significant. Low body mass index may be less likely to response to immunosuppressive treatment in patients with severe or very severe aplastic anemia.http://www.sciencedirect.com/science/article/pii/S259009862400006XPredictorsLymphocyte countNeutrophil countReticulocyte
spellingShingle Thanakrit Somprasertkul
Weerayaporn Trirattanapikul
Sittichai Khamsai
Verajit Chotmongkol
Kittisak Sawanyawisuth
Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
Medicine in Drug Discovery
Predictors
Lymphocyte count
Neutrophil count
Reticulocyte
title Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
title_full Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
title_fullStr Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
title_full_unstemmed Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
title_short Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
title_sort treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia
topic Predictors
Lymphocyte count
Neutrophil count
Reticulocyte
url http://www.sciencedirect.com/science/article/pii/S259009862400006X
work_keys_str_mv AT thanakritsomprasertkul treatmentresponseanditspredictorsofimmunosuppressivetherapyinpatientswithsevereorverysevereaplasticanemia
AT weerayaporntrirattanapikul treatmentresponseanditspredictorsofimmunosuppressivetherapyinpatientswithsevereorverysevereaplasticanemia
AT sittichaikhamsai treatmentresponseanditspredictorsofimmunosuppressivetherapyinpatientswithsevereorverysevereaplasticanemia
AT verajitchotmongkol treatmentresponseanditspredictorsofimmunosuppressivetherapyinpatientswithsevereorverysevereaplasticanemia
AT kittisaksawanyawisuth treatmentresponseanditspredictorsofimmunosuppressivetherapyinpatientswithsevereorverysevereaplasticanemia